Literature DB >> 23543137

MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma.

Biao Peng1, Su Hu, Qinming Jun, Dongdong Luo, Xun Zhang, Hailin Zhao, Dan Li.   

Abstract

MicroRNAs can coordinately repress multiple target genes and interfere with the biological functions of the cell, such as proliferation and apoptosis. In the present study, we report that miR-200b was downregulated in malignant glioma cell lines and specimens. Overexpression of miR-200b suppressed the proliferation and colony formation of glioma cells. An oncogene encoding cAMP responsive element-binding protein 1 (CREB1), which has been shown to be an important transcription factor involved in the proliferation, survival, and metastasis of tumor cells, was here confirmed as a direct target gene of miR-200b. CREB1 was also found to be present at a high level in human glioma tissues. This was inversely correlated with miR-200b expression. Ectopic expression of CREB1 attenuated the growth suppressive phenotypes of glioma cells caused by miR-200b. These results indicate that miR-200b targets the CREB1 gene and suppresses glioma cell growth, suggesting that miR-200b shows tumor-suppressive activity in human malignant glioma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543137     DOI: 10.1007/s11010-013-1626-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.

Authors:  Susanna Leskelä; Luis J Leandro-García; Marta Mendiola; Jorge Barriuso; Lucía Inglada-Pérez; Iván Muñoz; Beatriz Martínez-Delgado; Andrés Redondo; Javier de Santiago; Mercedes Robledo; David Hardisson; Cristina Rodríguez-Antona
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

Review 2.  Recent advances in therapy for glioblastoma.

Authors:  Jennifer Clarke; Nicholas Butowski; Susan Chang
Journal:  Arch Neurol       Date:  2010-03

Review 3.  MicroRNAs, cancer and cancer stem cells.

Authors:  Amy L Zimmerman; Shiyong Wu
Journal:  Cancer Lett       Date:  2010-10-20       Impact factor: 8.679

4.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 5.  MicroRNA control of signal transduction.

Authors:  Masafumi Inui; Graziano Martello; Stefano Piccolo
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03-10       Impact factor: 94.444

6.  Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues.

Authors:  Xinmin Zhang; Duncan T Odom; Seung-Hoi Koo; Michael D Conkright; Gianluca Canettieri; Jennifer Best; Huaming Chen; Richard Jenner; Elizabeth Herbolsheimer; Elizabeth Jacobsen; Shilpa Kadam; Joseph R Ecker; Beverly Emerson; John B Hogenesch; Terry Unterman; Richard A Young; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

7.  cAMP response element binding protein (CREB) overexpression CREB has been described as critical for leukemia progression.

Authors:  Martina Pigazzi; Emanuela Ricotti; Giuseppe Germano; Diego Faggian; Maurizio Aricò; Giuseppe Basso
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

Review 8.  Review of miR-200b and cancer chemosensitivity.

Authors:  Bing Feng; Rui Wang; Long-Bang Chen
Journal:  Biomed Pharmacother       Date:  2012-06-29       Impact factor: 6.529

9.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

10.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

View more
  23 in total

1.  MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.

Authors:  Jin Qian; Rui Li; Ying-Yi Wang; Yan Shi; Wen-Kang Luan; Tao Tao; Jun-Xia Zhang; Yi-Chang Xu; Yong-Ping You
Journal:  Mol Cell Biochem       Date:  2015-02-04       Impact factor: 3.396

Review 2.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

3.  MiR-122/Wnt/β-catenin regulatory circuitry sustains glioma progression.

Authors:  Guangzhi Wang; Yan Zhao; Yongri Zheng
Journal:  Tumour Biol       Date:  2014-05-27

4.  MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).

Authors:  Peng Li; Wan-Jiang Xue; Ying Feng; Qin-Sheng Mao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

5.  MicroRNA-506 inhibits esophageal cancer cell proliferation via targeting CREB1.

Authors:  Wen-Jian Yao; Yong-Lian Wang; Jian-Guo Lu; Ling Guo; Bo Qi; Zhi-Jun Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  miR-200b as a prognostic factor targets multiple members of RAB family in glioma.

Authors:  Qing Liu; Hailin Tang; Xiaoping Liu; Yiwei Liao; Haoyu Li; Zijin Zhao; Xianrui Yuan; Weixi Jiang
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

Review 7.  Circulating microRNA biomarkers for glioma and predicting response to therapy.

Authors:  Charlotte A Tumilson; Robert W Lea; Jane E Alder; Lisa Shaw
Journal:  Mol Neurobiol       Date:  2014-04-03       Impact factor: 5.590

8.  MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.

Authors:  YaSai Yao; Jian Hu; Zan Shen; RuYong Yao; ShiHai Liu; Yong Li; Hui Cong; XinGang Wang; WenSheng Qiu; Lu Yue
Journal:  J Cell Mol Med       Date:  2015-01-30       Impact factor: 5.310

9.  Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma.

Authors:  Lingxiang Yu; Xiaodong Guo; Peirui Zhang; Ruizhao Qi; Zhiwei Li; Shaogeng Zhang
Journal:  Onco Targets Ther       Date:  2014-05-29       Impact factor: 4.147

Review 10.  Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Mol Cancer       Date:  2014-02-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.